Associate Professor of Medicine, Bioinformatics, and Biostatistics
Boston University School of Medicine
Affiliate Member, Hariri Institute for Computing and CS&E
Affiliate Member, Broad Institute of MIT & Harvard
Dr. Monti is a computational biologist and cancer genomics specialist who has developed a novel technology for rapid and economically screening thousands of chemicals for their ability to influence expression of virtually all cancer-related signaling pathways within human cells, including but not limited to the AhR, the Wnt, and the NF-kB pathways. The National Institute of Health (NIH) has acknowledged that this type of high-throughput screening assay may be the only practical way to determine how we are affected by mixtures of environmental pollutants.